ODYSSEY MONO: Effect of Alirocumab 75 Mg Subcutaneously Every 2 Weeks As Monotherapy Versus Ezetimibe Over 24 Weeks
Year: 2015
Type: article
Source: Future Cardiology
DOI: 10.2217/fca.14.82
Authors: Eli M Roth, James M McKenney
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2018010993
